04052nam 2201285z- 450 991055734920332120231214132942.0(CKB)5400000000042398(oapen)https://directory.doabooks.org/handle/20.500.12854/77108(EXLCZ)99540000000004239820202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierCancer ImmunologyBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 electronic resource (316 p.)3-0365-2573-4 3-0365-2572-6 The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.MedicinebicsscNKG2DCAR TIL-7prostate cancercell therapyCD19-CAR-TB cell aplasiaKIRPD-1inhibitory CARtumor-infiltrating lymphocytestumor microenvironmentimmunotherapyNK cellscancer stem cells (CSCs)antibody-dependent cellular cytotoxicity (ADCC)differentiationcytotoxicityIFN-γosteoclastsMICA/B mAbDNA methylationRNA methylationS-adenosylmethionine (SAM)cancerinnate immunityadaptive immunityT cellsm6APD-L1resistanceimmune checkpointscancer vaccinecombination immunotherapyTCR diversityorgan transplantationcarcinomaepidemiologic studiesimmunosuppressionCTLA-4Treg cellsimmune checkpoint inhibitorsCD28antigen-presenting cellsIL15colon cancermelanomauvealBAP1anti-PD-1anti-CTLA-4TILclassical and endemic Kaposi Sarcomasystemic treatmentmulti-state modellingtreatment free intervalchemotherapyinterferontriple negative breast cancerimmunomodulationbispecific antibodysortase Achemo-enzymatic approachanti-CD20 antibodyFabBiFabcolorectal cancerdendritic cellsAtypical Chemokine Receptor 4 (ACKR4)T-cell primingimmune checkpoint blockadeprimary liver cancerkynurenine pathwayimmune evasionindoleamine 2,3 dioxygenase 1tryptophan 2,3 dioxygenase 2IDO inhibitorantigen presenting cellsMedicineSubramanian Subreeedt1289224Zhao XiandaedtSubramanian SubreeothZhao XiandaothBOOK9910557349203321Cancer Immunology3021107UNINA